Medtronic Plc (MDT)

97.90
0.58 0.60
NYSE : Health Technology
Prev Close 97.32
Open 97.82
Day Low/High 97.45 / 98.08
52 Wk Low/High 81.66 / 100.15
Volume 822.23K
Avg Volume 5.59M
Exchange NYSE
Shares Outstanding 1.34B
Market Cap 130.72B
EPS 2.30
P/E Ratio 27.01
Div & Yield 2.00 (2.05%)
Stock Futures Rise but in 'Wait-and-See' Mode Ahead of Trump-Xi Meeting, U.S. Jobs Report

Stock Futures Rise but in 'Wait-and-See' Mode Ahead of Trump-Xi Meeting, U.S. Jobs Report

Stock futures are higher Thursday as investors remain cautious ahead of the U.S. jobs report on Friday and meeting between Donald Trump and China's Xi Jinping.

Medtronic Stock Gaining on Reported Deal to Sell Medical Supplies Unit

Medtronic Stock Gaining on Reported Deal to Sell Medical Supplies Unit

Medtronic is said to be close to a $6 billion deal to sell its medical supplies unit.

5 Things You Must Know Before the Market Opens Thursday

5 Things You Must Know Before the Market Opens Thursday

U.S. stock futures turn higher Thursday after the Fed commits to further monetary tightening in 2017. Investors also are anticipating the meeting between Donald Trump and Chinese leader Xi Jinping.

Intel Elects Two New Members to Its Board

Intel Elects Two New Members to Its Board

Intel added executives from Medtronic and Boeing to its board of directors.

What's Behind IBM's Big Artificial Intelligence Deal With Salesforce

What's Behind IBM's Big Artificial Intelligence Deal With Salesforce

The tie-up between Big Blue and the cloud CRM software leader highlights IBM's unique AI position and strengths.

IBM's Deal With Salesforce Highlights the Company's Unique AI Position

IBM's Deal With Salesforce Highlights the Company's Unique AI Position

When it comes to AI solutions meant for specific industries, IBM has a lot of expertise and the ability to cast a broad net.

Masimo's Stock Is a Great Buy Right Now

Masimo's Stock Is a Great Buy Right Now

This patient-monitoring device-maker has plenty of room for growth.

Cramer: Money's Being Thrown at Almost Everything in the Market

Cramer: Money's Being Thrown at Almost Everything in the Market

There are nearly too many surging sectors to count.

Cramer: Money's Being Thrown at Almost Everything in the Market

Cramer: Money's Being Thrown at Almost Everything in the Market

There are nearly too many surging sectors to count.

We Might See a Pullback in Bonds Sometime This Week

In one scenario, we crack these levels and then come back and retest on the pullback.

Exiting Two Retail Positions

We'll sell our remaining shares in Panera and Costco to protect profits and move on.

Meet 4 Women Serving on the Boards of 4 Companies at the Same Time

Meet 4 Women Serving on the Boards of 4 Companies at the Same Time

Four women serve on the boards of four S&P 500 companies at the same time.

Four Women Match Men Sitting on the Most S&P 500 Boards

Four Women Match Men Sitting on the Most S&P 500 Boards

More than a dozen people sit on the four boards for components of the S&P 500, of which four are women.

Medtronic Earnings Rebound in Third Quarter, Shares Climb

Medtronic Earnings Rebound in Third Quarter, Shares Climb

The company discusses potential share repurchases and its acquisition strategy.

Market Recon: Brace Yourself, Big Retail Reports This Week

Market Recon: Brace Yourself, Big Retail Reports This Week

With Macy's, Walmart and other retailers reporting this week, steel yourself for the bad news.

Health Care ETF Has Been Ailing

Health Care ETF Has Been Ailing

You might want to review your holdings in the sector.

DexCom Is a Great Healthcare Stock to Buy Now

DexCom Is a Great Healthcare Stock to Buy Now

The continuous glucose monitor maker is an excellent growth opportunity.

The S&P 500 Companies With the Most Diverse Boards

The S&P 500 Companies With the Most Diverse Boards

The most ethnically and gender diverse boards may surprise you.

The Upside Is Limited, but the Downside Doesn't Look Terrible

While breadth has faltered, it has not weakened.

U.S. Eases Sanctions on Russian Intelligence Agency, Making Life Easier for Tech Exporters

U.S. Eases Sanctions on Russian Intelligence Agency, Making Life Easier for Tech Exporters

The Treasury Department's move to ease sanctions on Russian intelligence agency FSB was good news for Russia ETFs -- and U.S. exporters.

Honeywell and 4 More Stock Charts to Watch

Honeywell and 4 More Stock Charts to Watch

Here's how to use charts to trade five stocks, including Dow Chemical and Honeywell.

Dow Chemical, Honeywell, Medtronic Not Done Rallying

Dow Chemical, Honeywell, Medtronic Not Done Rallying

Some of Wall Street's biggest stocks are teetering on the edge of breakout territory this week. Here are five of them.

Earnings Key to Next Week's Winners: Cramer's 'Mad Money' Recap (Friday 1/13/17)

Earnings Key to Next Week's Winners: Cramer's 'Mad Money' Recap (Friday 1/13/17)

Jim Cramer highlights bank, health-care companies reporting next week and what to watch.

3 Rising Dividend Stocks Right on Target for 2017

3 Rising Dividend Stocks Right on Target for 2017

Dividend growers Texas Instruments, Accenture and Medtronic are superior to companies that simply sport high dividend yields, says one portfolio manager.

What Exactly Are Investors Missing Out On?

Statistically, Friday's rally was not the best one.

3 Health Care Giants Set to Ride Out Washington's Sound and Fury

3 Health Care Giants Set to Ride Out Washington's Sound and Fury

An attempt to repeal the Affordable Care Act and the brewing policy war between President-elect Donald Trump and the Democrats won't slow these three health sector juggernauts.

'Mad Money' Lightning Round: Jim Cramer Sees Opportunity in Sirius and Medtronic

'Mad Money' Lightning Round: Jim Cramer Sees Opportunity in Sirius and Medtronic

Sirius, Medtronic and Carlyle could be money makers in 2017, says Jim Cramer.

Cramer's 'Mad Money' Recap (Tuesday 1/3/17): Better Buying Opportunities Are Lurking

Cramer's 'Mad Money' Recap (Tuesday 1/3/17): Better Buying Opportunities Are Lurking

Jim Cramer outlines what he thinks this market needs to keep the Trump rally rolling in 2017.

Analysts' Actions -- Medtronic, Nokia, Paccar, Verizon and More

Analysts' Actions -- Medtronic, Nokia, Paccar, Verizon and More

Here are Tuesday's top research calls, including downgrades for Medtronic, Nokia and Paccar, and an upgrade for Verizon.

Don't Be So Quick to Be Bullish

The ETF put/call ratio chart indicates some limited upside.

TheStreet Quant Rating: A- (Buy)